MAPT and Alzheimer disease: However, in later stages of AD, persistent microglial activation by amyloid plaques results in a shift from neuroprotective to neurotoxic microglial phenotypes that produce pro-inflammatory cytokines, which in turn can increase Aβ production, neural damage, and are related to tau-mediated neurodegeneration [58, 59].